National Health Investors Inc insider trading
Every open-market purchase and sale by National Health Investors Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following National Health Investors Inc’s insiders pay?
From January 5, 2010 to June 15, 2026, 13 insiders reported 57 open-market purchases and 47 sales not made under a pre-set plan in National Health Investors Inc. Twelve months after each purchase was reported, the shares were +12.2% against the S&P 500 on average (median +9.4%), over 55 purchases with a full year of prices; 66% beat the index. After sales, the shares moved −4.0% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 13, 2010 into $41,479 by November 2, 2026, +9.2% a year. It held shares 72% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $53,089 (+10.9% a year), and held throughout $89,354 (+14.6%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Mccabe Robert A Jr | Director | 15 | +5.8% (14) | 50% | 9 | −2.3% (9) | June 15, 2026 |
| Webb Robert T | Director | 8 | +30.8% (8) | 100% | 7 | +7.0% (7) | December 1, 2021 |
| Gaines Kristin Sallee | Chief Credit Officer | 2 | +17.4% (2) | 50% | 9 | −5.7% (9) | December 14, 2018 |
| Hutchens James Justin | CEO and President | 5 | −2.1% (5) | 60% | 6 | −5.6% (6) | April 2, 2015 |
| Mendelsohn D. Eric | CEO and President | 10 | +26.7% (9) | 100% | 1 | −41.0% (1) | June 5, 2026 |
| Hopkins Roger R | Chief Accounting Officer | 2 | +15.2% (2) | 50% | 5 | +8.6% (5) | March 29, 2016 |
| Adams Robert G | Director | 6 | −20.2% (6) | 17% | 0 | — | December 15, 2022 |
| Pascoe Kevin Carlton | Chief Investment Officer | 1 | +35.0% (1) | 100% | 5 | −24.4% (5) | February 25, 2020 |
| Jobe James R | Director | 4 | +12.9% (4) | 50% | 1 | −37.1% (1) | August 31, 2023 |
| Adams W Andrew | Chief Executive Officer | 2 | +18.6% (2) | 50% | 2 | +5.1% (2) | March 25, 2020 |
| Welch Ted H | Director | 0 | — | — | 2 | +7.2% (2) | February 24, 2011 |
| Spaid John L | Exec. VP of Finance | 1 | +23.6% (1) | 100% | 0 | — | February 23, 2018 |
| Swafford Charlotte A | Director | 1 | +18.8% (1) | 100% | 0 | — | February 28, 2024 |
When several insiders traded National Health Investors Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of National Health Investors Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 7 buying crowds with six months of prices, it averaged +5.9% against the index. After 6 selling crowds, −0.4%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| June 30, 2026 | 2 buying | −15.2% | not yet | not yet |
| January 31, 2022 | 2 buying | −3.0% | +24.2% | +15.9% |
| September 30, 2021 | 2 buying | −2.6% | +7.8% | +27.8% |
| May 29, 2020 | 4 buying | +1.0% | +3.6% | −13.2% |
| December 31, 2018 | 3 selling | −9.6% | −12.4% | −17.6% |
| February 28, 2018 | 3 buying | +14.7% | +17.5% | +22.0% |
| June 30, 2016 | 3 selling | +4.0% | −8.6% | −7.0% |
| May 29, 2015 | 2 buying | −7.8% | −7.1% | +9.9% |
| May 30, 2014 | 2 buying | −0.2% | +0.1% | −0.4% |
| September 30, 2013 | 2 buying | −8.9% | −4.5% | −13.8% |
| December 31, 2012 | 3 selling | +7.3% | −2.2% | −27.7% |
| June 29, 2012 | 4 selling | −4.0% | +8.4% | +4.5% |
← Back to National Health Investors Inc · Funds · Politicians